LIVZON Operating Income from 2010 to 2026
| LP6 Stock | EUR 3.02 0.02 0.66% |
Operating Income | First Reported 2010-12-31 | Previous Quarter 3.3 B | Current Value 2.7 B | Quarterly Volatility 304 M |
Check LIVZON PHARMAC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LIVZON PHARMAC's main balance sheet or income statement drivers, such as Tax Provision of 455.2 M, Net Interest Income of 193.2 M or Interest Income of 300.7 M, as well as many indicators such as . LIVZON financial statements analysis is a perfect complement when working with LIVZON PHARMAC Valuation or Volatility modules.
LIVZON | Operating Income |
The Operating Income trend for LIVZON PHARMAC GRP offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether LIVZON PHARMAC is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest LIVZON PHARMAC's Operating Income Growth Pattern
Below is the plot of the Operating Income of LIVZON PHARMAC GRP over the last few years. Operating Income is the amount of profit realized from LIVZON PHARMAC GRP operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of LIVZON PHARMAC GRP is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. LIVZON PHARMAC's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LIVZON PHARMAC's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
LIVZON Operating Income Regression Statistics
| Arithmetic Mean | 2,333,191,053 | |
| Geometric Mean | 2,317,153,088 | |
| Coefficient Of Variation | 13.03 | |
| Mean Deviation | 217,118,168 | |
| Median | 2,187,631,294 | |
| Standard Deviation | 303,950,249 | |
| Sample Variance | 92385.8T | |
| Range | 1.1B | |
| R-Value | 0.67 | |
| Mean Square Error | 53909.5T | |
| R-Squared | 0.45 | |
| Significance | 0 | |
| Slope | 40,509,309 | |
| Total Sum of Squares | 1478172.1T |
LIVZON Operating Income History
About LIVZON PHARMAC Financial Statements
LIVZON PHARMAC stakeholders use historical fundamental indicators, such as LIVZON PHARMAC's Operating Income, to determine how well the company is positioned to perform in the future. Although LIVZON PHARMAC investors may analyze each financial statement separately, they are all interrelated. For example, changes in LIVZON PHARMAC's assets and liabilities are reflected in the revenues and expenses on LIVZON PHARMAC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LIVZON PHARMAC GRP. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | 3.3 B | 2.7 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in LIVZON Stock
LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.